MSB 1.01% 98.5¢ mesoblast limited

Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients, page-90

  1. 332 Posts.
    lightbulb Created with Sketch. 17
    "Ryoncil has shown results in 3 to 4 days"

    That's not true. As far as we know, Ryoncil (or Remestemcel-L) hasn't been administered to a single COVID-19 patient. Let's keep it factual (or at least somewhere near!!!)
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
98.5¢
Change
-0.010(1.01%)
Mkt cap ! $1.136B
Open High Low Value Volume
$1.00 $1.01 98.0¢ $391.8K 395.3K

Buyers (Bids)

No. Vol. Price($)
6 39787 98.5¢
 

Sellers (Offers)

Price($) Vol. No.
99.0¢ 30487 25
View Market Depth
Last trade - 10.41am 20/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.